Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mapatumumab with Cisplatin and Radiotherapy in Advanced Cervical Cancer
NCT01088347Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2010
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of mapatumumab in Cervical Cancer (CC), sponsored by University Medical Center Groningen. Started Mar 2010; status: completed.
02
Drugs
mapatumumab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01088347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088347.